UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1943-01-01
- Employees
- 8.1K
- Market Cap
- -
Neo RQI: The Effect of Neonatal Resuscitation Quality Improvement Cart Booster Training Skills Retention
Not Applicable
Completed
- Conditions
- Ventilatory Failure
- Interventions
- Behavioral: Booster Training with the Neonatal Resuscitation Quality Improvement Cart
- First Posted Date
- 2021-12-07
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 155
- Registration Number
- NCT05147922
- Locations
- 🇺🇸
University of Texas, Southwestern, Dallas, Texas, United States
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
Phase 1
Recruiting
- Conditions
- AmyloidosisAL Amyloidosis
- Interventions
- Drug: Belantamab mafodotin 2.5 mg/kg (8 weeks)Drug: Belantamab mafodotin 1.9 mg/kg (8 weeks)Drug: Belantamab mafodotin 1.9 mg/kg (12 weeks)Drug: Belantamab mafodotin 1.4 mg/kg (12 weeks)Drug: Belantamab mafodotin 1.0 mg/kg (12 weeks)Drug: Belantamab mafodotin every 4 weeks, 6 weeks,8 weeks, or 12 weeks as determined by Part 1 recommended dosages
- First Posted Date
- 2021-12-06
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 37
- Registration Number
- NCT05145816
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸UT Southwestern Medical Center, Dallas, Texas, United States
🇺🇸Stanford Cancer Institute, Stanford, California, United States
Value of Potassium Magnesium Citrate in Preventing and Treating Hypertension in African Americans
Phase 2
Not yet recruiting
- Conditions
- Hypertension
- Interventions
- Drug: KMgCitDrug: Placebo
- First Posted Date
- 2021-12-06
- Last Posted Date
- 2025-01-01
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 45
- Registration Number
- NCT05145309
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Impact of Empagliflozin on Functional Capacity in Heart Failure With Preserved Ejection Fraction
Phase 3
Completed
- Conditions
- Heart Failure with Preserved Ejection FractionHeart Failure, DiastolicDiabetes Mellitus
- Interventions
- First Posted Date
- 2021-12-01
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 8
- Registration Number
- NCT05139472
- Locations
- 🇺🇸
Institute for Exercise and Environmental Medicine, Dallas, Texas, United States
🇺🇸University of Texas Southwestern Medical Center, Dallas, Texas, United States
Radiofrequency Ablation of Adenomyosis
Not Applicable
Recruiting
- Conditions
- Adenomyosis
- Interventions
- Device: RF Treatment
- First Posted Date
- 2021-11-23
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT05130190
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Strategies to Enhance Recruitment and Retention of Black Individuals Into Clinical Trials for Substance Use Disorders
Completed
- Conditions
- Substance Use Disorders
- First Posted Date
- 2021-11-17
- Last Posted Date
- 2024-08-13
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 65
- Registration Number
- NCT05124119
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
Preventing Cognitive Decline by Reducing BP Target Trial
Not Applicable
Recruiting
- Conditions
- Cognitive DeclineHypertensionBlood Pressure
- Interventions
- Other: Clinical Support Decision Tool
- First Posted Date
- 2021-11-03
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 4000
- Registration Number
- NCT05106036
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin
Completed
- Conditions
- Hemifacial SpasmCervical DystoniaBlepharospasmLimb DystoniaSpasticity, MuscleFragments of Torsion Dystonia
- First Posted Date
- 2021-11-02
- Last Posted Date
- 2022-06-30
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 105
- Registration Number
- NCT05103202
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
Effect of Video-Based Coaching on Resident Laparoscopic Surgical Skills
Not Applicable
Completed
- Conditions
- Laparoscopic Salpingectomy
- Interventions
- Other: Video Coaching
- First Posted Date
- 2021-11-02
- Last Posted Date
- 2023-08-24
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 28
- Registration Number
- NCT05103449
- Locations
- 🇺🇸
Parkland Memorial Hospital, Dallas, Texas, United States
Oral Zinc Supplementation to Enhance Botulinum Neurotoxin Response
Not Applicable
Completed
- Conditions
- Dystonia, Focal
- Interventions
- Dietary Supplement: Zinc AcetateDietary Supplement: Placebo
- First Posted Date
- 2021-10-27
- Last Posted Date
- 2021-10-27
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 54
- Registration Number
- NCT05095493
© Copyright 2025. All Rights Reserved by MedPath